Sutro Biopharma, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 159
Rang # Quantité totale PI 8 141
Note d'activité PI 2,9/5.0    106
Rang # Activité PI 6 521
Symbole boursier
ISIN US8693671021
Capitalisation 231M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

74 14
10 0
60 0
1
 
Dernier brevet 2025 - Anti-ror1 antibody conjugates, c...
Premier brevet 2010 - Dual charging system for selecti...
Dernière marque 2025 - SUTRO
Première marque 2012 - SUTRO BIOPHARMA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in...
2024 Invention Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods...
Invention Anti-folate receptor antibodies, compositions comprising anti-folate receptor antibodies and meth...
Invention Anti-bcma antibodies and treatment methods. The present disclosure relates to antibodies that se...
Invention E. coli strains. E. coliE. coliE. coliE. coli cells comprise an RF2 variant that has greater acti...
2023 Invention Hemiasterlin derivatives for conjugation and therapy. Provided herein are hemiasterlin derivativ...
Invention Interferon alpha polypeptides and conjugates. The present disclosure generally relates to interfe...
Invention Anti-folate receptor conjugate therapy for cancer treatment. The present disclosure relates to t...
Invention Anti-cd3 antibodies, compositions comprising anti-cd3 antibodies and methods of making and using ...
Invention Interleukin-18 variants and uses thereof. The present disclosure provides IL-18 polypeptides with...
Invention Spray dried extract. This disclosure provides for an improved method of stabilizing spray-dried b...
Invention Spray dried extract. This disclosure provides for an improved method of stabilizing spray-dried ...
Invention Antibodies with engineered ch2 domains, compositions thereof and methods of using the same. The ...
Invention Protease/enzyme cleavable linker-payloads and protein conjugates. Provided herein are compounds, ...
Invention Anti-ror1 antibodies and antibody conjugates, compositions comprising anti-ror1 antibodies or ant...
Invention Il-12 mutants with reduced toxicity, compositions thereof and methods of using the same. The pres...
Invention Beta-glucuronide linker-payloads, protein conjugates thereof, and methods thereof. Provided here...
Invention Β-glucuronide linker-payloads, protein conjugates thereof, and methods thereof. Provided herein a...
Invention Anti-cd74 antibody conjugates, compositions comprising anti cd74 antibody conjugates and methods ...
Invention Sting agonist compounds. The present disclosure is related to STING agonists, pharmaceutical comp...
P/S Medical scientific research, medical scientific development, and medical scientific testing of an...
Invention Immunomodulator antibody drug conjugates and uses thereof. Provided herein are compounds, trifun...
P/S Pharmaceutical and biological preparations for the immune system targeting immuno-oncology pathwa...
2022 Invention Modified amino acids. Provided herein are modified amino acids comprising an azido group, polype...
Invention Anti-folate receptor conjugate cancer therapy. The present disclosure relates to therapies with ...
Invention Anti-folate receptor conjugate cancer therapy. The present disclosure relates to therapies with a...
Invention Formulations for drying bacterial cell extracts. This invention provides for an improved method o...
Invention E. coli strains having an oxidative cytoplasm. This disclosure provides an E. coli strain, which...
Invention Anti-folate receptor conjugate combination therapy with bevacizumab. The present disclosure rela...
Invention Anti-folate receptor conjugate combination therapy with bevacizumab. The present disclosure relat...
Invention Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their pr...
2021 Invention Fluorenylmethyloxycarbonyl and fluorenylmethylaminocarbonyl compounds, protein conjugates thereof...
Invention Method for large scale production of antibodies using a cell-free protein synthesis system. Desc...
Invention Method for large scale production of antibodies using a cell-free protein synthesis system. Descr...
Invention Anti-epcam antibodies, compositions comprising anti-epcam antibodies and methods of making and us...
Invention Method of fast comparison of molecular shapes. An open-source fast non-alignment-based method of ...
Invention Anti-tim-3 antibodies, compositions comprising anti-tim-3 antibodies and methods of making and us...
Invention Methods of producing full-length antibodies using e.coli. This disclosure provides a method of pr...
Invention Methods of producing full-length antibodies using e.coli. E.coliE. coliE. coliE. coli ranges from...
Invention Methods of producing full-length antibodies using e. coli. This disclosure provides a method of ...
Invention Anti-cd74 antibodies, compositions comprising anti-cd74 antibodies and methods of using anti-cd74...
Invention Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of t...
2020 P/S Bacterial extract preparations for the cell free production of therapeutic proteins or peptides f...
P/S Bacterial lysate preparations for the cell free production of therapeutic proteins or peptides fo...
Invention 1-(4-(aminomethyl)benzyl)-2-butyl-2h-pyrazolo[3,4-c]quinolin-4-amine derivatives and related comp...
Invention 5h-pyrrolo[3,2-d]pyrimidine-2,4-diamino compounds and antibody conjugates thereof. The present d...
Invention Anti-bcma antibody conjugates. The present disclosure relates to antibody conjugates with bindin...
2019 Invention E. coli strains having an oxidative cytoplasm. E. coli strain has an oxidative cytosol and can be...
Invention Combination therapies with anti-folate receptor antibody conjugates. The present disclosure rela...
2018 P/S Pharmaceutical preparations, namely, proteins and derivatives thereof for prophylactic, diagnosti...
2013 P/S Customized manufacture of therapeutic proteins for the treatment or prevention of diseases by pha...
2012 P/S Manufacture of pharmaceutical preparations for others Pharmaceutical preparations, namely, protei...